Feb 25, 2022
Listen in as Dr. Mark Houston, the Director of the Hypertension Institute - tripled boarded in hypertension as an American Society of Hypertension specialist, a Fellow of the American Society of Hypertension, Internal Medicine, and Anti-aging medicine discusses the emerging strategies in cardiometabolic medicine.
Feb 24, 2022
Despite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate healthcare, among other factors. During this...
Feb 23, 2022
Listen in as Fatima Stanford, MD, Associate Professor of Medicine and Pediatrics, as well as Equity Director at Massachusetts General Hospital Endocrine Division, shares some practical pearls about addressing disparities in the management of obesity.
Feb 15, 2022
Tune in to hear Javed Butler, MD, renowned heart failure (HF) specialist and the principal investigator of several major HF trials, discuss the evolving paradigms of HF care, including the role of SGLT-2 inhibitors as part of foundational therapy, as well as other newer and emerging treatment options and their role in...